FdaApplication
NDA 021036
Identifiers
- fda_app_no: NDA021036
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 1999-07-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RELENZA | ZANAMIVIR | 5MG | POWDER;INHALATION |
1 product